Gamma-globulin inhibits superantigen-induced lymphocyte proliferation and cytokine production

Allergology International

Volumn 56, Issue 4, 2007, Pages 439-444

  Kato, Kumiko ^a   Sakamoto, Tatsuo ^a   Ito, Komei ^b  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI CHILDREN'S HEALTH AND MEDICAL CENTER   (Japan)

Author keywords

Neutralizing antibody; Pooled human immunoglobulin; Staphylococcal enterotoxin B; Superantigen

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; INTERLEUKIN 4; NEUTRALIZING ANTIBODY; STAPHYLOCOCCUS ENTEROTOXIN B; SUPERANTIGEN;

ARTICLE; CELL PROLIFERATION; CYTOKINE PRODUCTION; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; TOXIC SHOCK SYNDROME;

EID: 37349058628     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.O-06-462     Document Type: Article

References (15)

1. Schlievert PM. Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses. J. Allergy Clin. Immunol. 2001;108:S107-110.
2. Takahashi N, Nishida H, Kato H et al. Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period. Lancet 1998;351:1614-1619.
3. Matsubara K, Fukaya T, Miwa K et al. Development of serum IgM antibodies against superantigens of Staphylococ cus aureus and Streptococcus pyogenes in Kawasaki disease. Clin. Exp. Immunol. 2006;143:427-434.
4. Zollner TM, Wichelhaus TA, Hartung A et al. Colonization with superantigen-producing Staphylococcus aureus is associated with increased severity of atopic dermatitis. Clin. Exp. Allergy 2000;30:994- 1000.
5. Hauk PJ, Hamid QA, Chrousos GP, Leung DY. Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens. J. Allergy Clin. Immunol. 2000;105: 782-787.
6. Leung DY, Bloom JW. Update on glucocorticoid action and resistance. J. Allergy Clin. Immunol. 2003;111:3-22.
7. Li LB, Goleva E, Hall CF, Ou LS, Leung DY. Superantigen-induced corticosteroid resistance of human T cells occurs through activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK-ERK) pathway. J. Allergy Clin. Immunol. 2004;114:1059-1069.
8. Hauk PJ, Leung DY. Tacrolimu (FK506): New treatment approach in superantigen-associated diseases like atopic dermatitis? J. Allergy Clin. Immunol. 2001;107:391-392.
9. Takahashi N, Kato H, Imanishi K et al. Immunopathophysiological aspects of an emerging neonatal infectious disease induced by a bacterial superantigen. J. Clin. Invest. 2000;106:1409-1415.
10. Holtfreter S, Roschack K, Eichler P et al. Staphylococcus aureus carriers neutralize superantigens by antibodies specific for their colonizing strain: a potential explanation for their improved prognosis in severe sepsis. J. Infect. Dis. 2006;193:1275-1278.
11. Takata Y, Seki S, Dobashi H et al. Inhibition of IL-12 synthesis of peripheral blood mononuclear cells (PBMC) stimulated with a bacterial superantigen by pooled human immunoglobulin: implications for its effect on Kawasaki disease (KD). Clin. Exp. Immunol. 1998;114:311-319.
12. Aukrust P, Muller F, Svenson M, Nordoy I, Bendtzen K. Froland SS. Administration of intravenous immunoglobulin (IVIG) in vivo - down-regulatory effects on the IL-1 system. Clin. Exp. Immunol. 1999;115:136-143.
13. Campbell DE, Georgiou GM, Kemp AS. Pooled human immunoglobulin inhibits IL-4 but not IFN-gamma or TNF-alpha secretion following in vitro stimulation of mononuclear cells with Staphylococcal superantigen. Cytokine 1999;11:359-365.
14. Samuelsson A, Towers TL, Ravetch JV. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 2001;291:484- 486.
15. Strait RT, Morris SC, Finkelman FD. IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and Fc gamma RIIb crosslinking. J. Clin. Invest. 2006;116:833-841.